Jun 27, 2012 ... Samuel R. Denmeade,1* Annastasiah M. Mhaka,1 D. Marc Rosen,1 ... George
Wilding,3 Michael A. Carducci,1 Craig A. Dionne,4 Jesper V. Møller,2,5 Poul
Nissen,2,6 ...... Purified G202 for animal studies was provided by GenSpera Inc.
... Milowsky et al. with a PSMA antibody (clone 3E6; Dako) diluted 1:20.
May 5, 2009 ... Rabbit polyclonal anti-AR (N-20), Cyclin D1 (H-295), GADD34 (S-20), .... 2A), and
completion of the process of cellular fragmentation into Annexin V–positive
apoptotic bodies (30, 41, 42). ..... J.T. Isaacs and S.R. Denmeade: financial
interest, Genspera, Inc., and .... Singh P, Mhaka AM, Christensen SB, et al.
Sep 18, 2014 ... Applicant, Genspera, Inc. ... and (d) reacting the compound of Formula 6 with the
compound of ..... Sci., USA 1996;93:749- 753; Mhaka, A., et al, Cancer Biol Ther.
... by PSMA in vitro and is ~ 60-fold more toxic to PSMA expressing vs. ..... with
1.0 L of 6 M HC1 over 30 minutes (pH~3) a white slurry develops.
Feb 15, 2013 ... Reagents: G202 (GenSpera); Tasquinimod (Active Biotech ... HDAC4 specific
substrate; Bachem Inc.). ... Tris HCl pH 7.4 with 150 mmol/L NaCl/1% Triton and
protease ... Isaacs et al. .... 4.8 Æ 0.9% of tumor area in TasQ treated vs. ...
untreated control cells. D, TasQ dose-response inhibition of 3D EC.